 | Morphic Holding, Inc. | |||
| NGM : MORF || Location: United States | ||||
$27.69-1.06 (-3.69%) |
0.33 M | 27.55 - 29.05 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 5.904 M |
| March 15, 2024 | 6.138 M |
| Feb. 29, 2024 | 6.029 M |
| Feb. 15, 2024 | 5.900 M |
| Jan. 31, 2024 | 6.030 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.87 | -0.96 | -10.84% |
| 09/30/2023 | -0.97 | -0.73 | 25.01% |
| 06/30/2023 | -0.89 | -0.92 | -3.41% |
| 03/31/2023 | -0.83 | -0.90 | -8.59% |
| 12/31/2022 | -0.89 | -0.64 | 28.15% |
MORF Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 50.037M | Shares Float | 36.793M |
| Short Float | 5.904M | Market Cap | 1438.56M |
| Institution ownership | 91.50% | Insider ownership | 16.782% |
| Earnings Date | 04/24/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.59 | Forward EPS | -4.23 |